MD Biosciences, Inc is a leading preclinical contract research organization (CRO) specializing in pain, neurodegeneration, and neuroinflammation. With a team of experienced neuroscientists, they offer expertise in developing complex predictive studies to enhance the translatability of preclinical data. Their GLP-certified laboratory is fully equipped with behavioral suites and offers both rodent and pig models to bridge the gap between preclinical and clinical studies.
MD Biosciences, Inc goes beyond standard behavior analysis by utilizing outcomes comparable to those measured in patients, such as in vivo electrophysiology, to provide clinically relevant preclinical data. Their focus on bringing insight and methods that increase the value of each study and the translatability of the data makes them an expert partner dedicated to meeting drug development needs in the field of neuroinflammatory, neurodegenerative, pain, and other CNS diseases.
Generated from the website